![David Zhu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Zhu has worked as a Director at Bilayer Therapeutics, Inc. and as a Managing Partner at Kendall Capital Partners.
| Sociétés | Poste | Début |
|---|---|---|
Kendall Capital Partners Management LLC
 Kendall Capital Partners Management LLC Investment ManagersFinance Kendall Capital Partners seeks investment opportunities in companies located in the United States. The firm focuses on biotechnology, drug delivery, novel drug and diagnostics sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2021 |
Bilayer Therapeutics, Inc.
 Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Engages in drug development for chronic disorders | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Kendall Capital Partners Management LLC
Kendall Capital Partners Management LLC Investment ManagersFinance Kendall Capital Partners seeks investment opportunities in companies located in the United States. The firm focuses on biotechnology, drug delivery, novel drug and diagnostics sectors. It provides financing for early stage capital requirements. | Finance |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Engages in drug development for chronic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
